 JLL Capital Markets arranged the $8.5-million sale of Tri-Valley GMP, a 42,620-square-foot industrial biomanufacturing facility located at 4696 Willow Rd. in Pleasanton. A team led by senior director Erik Hanson represented the seller. The buyers were Cannae Partners and REALM.
The cGMP facility previously served as Gritstone bio’s Tri-Valley hub until it vacated this past February. The property benefits from significant improvements that transformed it into a state-of-the-art laboratory and manufacturing complex featuring 12 production rooms, ISO 5+ cleanroom space and comprehensive quality assurance and quality control laboratories, according to JLL.
Located within the Tri-Valley and 680 Corridor, the facility offers access to nearby amenities and transportation nodes, including Bay Area Rapid Transit stations and Interstates 680 and 580. Pleasanton reportedly commands the strongest research and development and lab tenant demand in the Tri-Valley, with nearly 300,000 square feet of flex and lab space absorbed over the past 24 months.
The post Former Gritstone Biomanufacturing Facility Changes Hands appeared first on Connect CRE.
​Â